Zai Lab CMO Dr. Harald Reinhart to retire; Dr. Rafael Amado to lead all Global R&D

Zai Lab Ltd

Dr. Harald Reinhart, President, Head of Global Development (NSAiID), retiring effective June 30, 2024.
Reinhart will remain as a senior advisor; no disagreements led to his retirement.
Dr. Rafael Amado expands role to President, Head of Global R&D upon Reinhart's retirement.
Amado previously President of Global Oncology R&D; now oversees all therapy areas.
CEO Samantha Du noted Reinhart built strong NSAiID team for continued growth under Amado.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Harald Reinhart

President, Head of Global Development, Neuroscience, Autoimmune and Infectious Diseases

ZLAB · Zai Lab Ltd

Effective: 2024-06-30
Filed: June 11, 2024, 7:59 PM ET

On June 11, 2024 , Zai Lab Limited (the “Company”) announced that Dr. Harald Reinhart, President, Head of Global Development, Neuroscience, Autoimmune and Infectious Diseases, has informed the Company that he has decided to retire, effective June 30, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Harald Reinhart retired as President, Head of Global Development, Neuroscience, Autoimmune and Infectious Diseases at Zai Lab Ltd.

Action: retired
Role: President, Head of Global Development, Neuroscience, Autoimmune and Infectious Diseases

Exact text from the filing

On June 11, 2024 , Zai Lab Limited (the “Company”) announced that Dr. Harald Reinhart, President, Head of Global Development, Neuroscience, Autoimmune and Infectious Diseases, has informed the Company that he has decided to retire, effective June 30, 2024.

View on SEC.gov

Zai Lab Ltd filing history →

Source: SEC EDGAR

accession 0001628280-24-027668

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.